Literature DB >> 649386

Toxic effects of ergotamine used for migraine.

E Hokkanen, O Waltimo, T Kallanranta.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 649386     DOI: 10.1111/j.1526-4610.1978.hed1802095.x

Source DB:  PubMed          Journal:  Headache        ISSN: 0017-8748            Impact factor:   5.887


× No keyword cloud information.
  7 in total

1.  Analgesic-induced chronic headache: long-term results of withdrawal therapy.

Authors:  H C Diener; J Dichgans; E Scholz; S Geiselhart; W D Gerber; A Bille
Journal:  J Neurol       Date:  1989-01       Impact factor: 4.849

2.  Systemic availability of ergotamine tartrate after three successive doses and during continuous medication.

Authors:  V Ala-Hurula; V V Myllylä; P Arvela; N T Kärki; E Hokkanen
Journal:  Eur J Clin Pharmacol       Date:  1979-11       Impact factor: 2.953

3.  Low-dose propranolol therapy for aborting migraine.

Authors:  H J Featherstone
Journal:  West J Med       Date:  1983-03

4.  Autonomic dysaesthesia due to ergot toxicity.

Authors:  P J Evans; J W Lloyd; K M Peet
Journal:  Br Med J       Date:  1980-12-13

5.  Severe vascular spasm due to erythromycin-ergotamine interaction.

Authors:  H Francis; A Tyndall; J Webb
Journal:  Clin Rheumatol       Date:  1984-06       Impact factor: 2.980

6.  Abuse and paradoxical effects of analgesic drug mixtures.

Authors:  R Wörz
Journal:  Br J Clin Pharmacol       Date:  1980-10       Impact factor: 4.335

Review 7.  Sumatriptan. A reappraisal of its pharmacology and therapeutic efficacy in the acute treatment of migraine and cluster headache.

Authors:  G L Plosker; D McTavish
Journal:  Drugs       Date:  1994-04       Impact factor: 9.546

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.